Hostname: page-component-74656f9884-npj9w Total loading time: 0 Render date: 2026-11-08T02:19:17.998Z Has data issue: false hasContentIssue false

Paeoniflorin inhibits TGF-β1-mediated collagen production by Schistosoma japonicum soluble egg antigen in vitro

Published online by Cambridge University Press:  24 May 2007

D. CHU
Affiliation:
Institute of Clinical Pharmacology, Anhui Medical Universityand the Key Laboratory of Antiinflammatory-immunopharmacology, Anhui, China Institute of Zoonoses of Anhui Medical University and the Key Laboratory of Gene Resource Utilization for Severe Diseases (Anhui Medical University), Ministry of Education of China
Q. LUO
Affiliation:
Institute of Zoonoses of Anhui Medical University and the Key Laboratory of Gene Resource Utilization for Severe Diseases (Anhui Medical University), Ministry of Education of China
C. LI
Affiliation:
Institute of Zoonoses of Anhui Medical University and the Key Laboratory of Gene Resource Utilization for Severe Diseases (Anhui Medical University), Ministry of Education of China
Y. GAO
Affiliation:
Institute of Clinical Pharmacology, Anhui Medical Universityand the Key Laboratory of Antiinflammatory-immunopharmacology, Anhui, China Institute of Zoonoses of Anhui Medical University and the Key Laboratory of Gene Resource Utilization for Severe Diseases (Anhui Medical University), Ministry of Education of China
L. YU
Affiliation:
Institute of Clinical Pharmacology, Anhui Medical Universityand the Key Laboratory of Antiinflammatory-immunopharmacology, Anhui, China Institute of Zoonoses of Anhui Medical University and the Key Laboratory of Gene Resource Utilization for Severe Diseases (Anhui Medical University), Ministry of Education of China
W. WEI
Affiliation:
Institute of Clinical Pharmacology, Anhui Medical Universityand the Key Laboratory of Antiinflammatory-immunopharmacology, Anhui, China
Q. WU
Affiliation:
Department of Pathology, Anhui Medical University
J. SHEN*
Affiliation:
Institute of Clinical Pharmacology, Anhui Medical Universityand the Key Laboratory of Antiinflammatory-immunopharmacology, Anhui, China Institute of Zoonoses of Anhui Medical University and the Key Laboratory of Gene Resource Utilization for Severe Diseases (Anhui Medical University), Ministry of Education of China
*
*Corresponding author: Institute of Zoonoses of Anhui Medical University and the Key Laboratory of Gene Resource Utilization for Severe Diseases, No. 81, Meishan Road, Hefei, Anhui, China. Tel./Fax: +86 551 5161057. E-mail: jlshen@ahmu.edu.cn
Rights & Permissions [Opens in a new window]

Summary

The main pathological characteristics of hepatic fibrosis in schistosomiasis are the proliferation of hepatic stellate cells (HSCs) and the deposition of collagen type I (Col I) and collagen type III (Col III). Transforming growth factor beta-1 (TGF-β1) plays an important role in hepatic fibrosis. Paeoniflorin (PAE) has been reported to have immunoregulatory effects; however, the mechanism of its anti-hepatic fibrosis in S. japonicum has not been elucidated. In the present study, we found that mouse peritoneal macrophages (PMφs) stimulated by soluble egg antigen (SEA) of S. japonicum could secrete TGF-β1, and the TGF-β1 in the peritoneal macrophage-conditioned medium (PMCM) could induce proliferation of HSCs and secretion of Col I and III. We selected PMCM at 1:2 dilution as the optimum PMCM (OPMCM). Then we treated HSCs pre-incubated with OPMCM with PAE, and found that the inhibition of HSC proliferation or Col I and III production were closely correlated with the concentration of PAE. Further investigation found that PAE significantly decreased the Smad3 transcription and phosphorylation in HSCs stimulated by OPMCM. In conclusion, SEA plays a key role in hepatic fibrosis by inducing TGF-β1 from PMφs. PAE can exert anti-fibrogenic effects by inhibiting HSCs proliferation and down-regulating Smad3 expression and phosphorylation through TGF-β1 signalling.

Information

Type
Research Article
Copyright
Copyright © Cambridge University Press 2007
Figure 0

Fig. 1. Effect of various concentrations SEA on secretion of TGF-β1 from PMϕs. PMϕs were exposed to SEA (0, 2·5, 5, 10, 20, 40 mg/l) for 48 h. TGF-β1 content in the supernatants was assayed by ELISA. ■ There was statistical significance among all groups (P<0·05). Each bar represents the mean and standard deviation of triplicate determinations and data presented are representative of 3 independent experiments.

Figure 1

Fig. 2. Effect of PMCM on HSC proliferation. HSCs were cultured with or without stimulated PMCM for 48 h, and then HSC proliferation was detected by MTT colorimetric assay. Control, DMEM containing 0·5% FBS; stimulated PMCM dilution, stimulated PMCM:DMEM (v/v) containing 0·5% FBS. ▲P<0·01 compared with control group. Each bar represents the mean and standard deviation of triplicate determinations and data presented are representative of 3 independent experiments.

Figure 2

Fig. 3. Effect of stimulated PMCM on Col I or III secretion from HSCs. HSCs were cultured with or without stimulated PMCM for 72 h, and then Col I or III concentration in supernatants was determined by ELISA. Control, DMEM containing 0·5% FBS; stimulated PMCM dilution, stimulated PMCM:DMEM (v/v) containing 0·5% FBS. ■P<0·01 compared with the control group and P<0·05 compared among these groups; ▲P<0·01 compared with the control group and P<0·05 compared among these groups. Data from 3 experiments (each in triplicate) were normalized for HSC layer protein concentration per plate as Col I or Col III content (ng) per μg protein.

Figure 3

Table 1. Effect of TGF-β1 in PMCM on HSCs proliferation and Col I and Col III secretion by HSCs (means±s.d., n=6)(Control group, DMEM containing 0·5% FBS.)

Figure 4

Fig. 4. Effect of PAE on proliferation of HSCs stimulated by OPMCM. HSCs were treated with OPMCM for 12 h before being treated with PAE (0, 7·5, 15, 30, 60, 120 mg/l) or colchicine (1 μmol/l) for 48 h, and then HSC proliferation was detected by MTT colorimetric assay. The negative control contained PAE at 0 mg/l; the blank control was PMCM containing neither HSCs nor PAE. •P>0·05 compared with the colchicine group; ▲P<0·01 compared with the control. Each bar represents the mean and standard deviation of triplicate determinations and data presented are representative of 3 independent experiments.

Figure 5

Fig. 5. Effect of PAE on Col I or III secreted by OPMCM-stimulated HSCs. HSCs were treated with OPMCM for 12 h before being treated with PAE (0, 7·5, 15, 30, 60, 120 mg/l) or SB-431542 (10 μmol/l) for 72 h, and then Col I or III concentration in supernatants was determined by ELISA. The negative control contained PAE at 0 mg/l; the blank control was PMCM containing neither HSCs nor PAE. ■ There was statistical significance among these groups (P<0·01); ▲ there was statistical significance among these groups (P<0·05). Each bar represents the mean and standard deviation of triplicate determinations and data presented are representative of 3 independent experiments.

Figure 6

Fig. 6. PAE inhibits Col Iα1 and Col IIIα1 gene expression in OPMCM-stimulated HSCs. Cells were treated with OPMCM for 12 h before adding different PAE concentrations ranging from 0 to 120 mg/l for 12 h incubation for RT-PCR analysis or 24 h incubation for Western blotting. (A) Levels of Col Iα1 and Col IIIα1 mRNA were determined using RT-PCR. (B) Levels of Col Iα1 and Col IIIα1 proteins were measured by Western blotting. (C) Values of densitometric scan are means±s.d. of 3 experiments. Experiments were performed in triplicate and data presented are representative of 3 independent experiments.

Figure 7

Fig. 7. SB-431542 specifically down-regulates the expression of Smad2/3 phosphorylation in OPMCM-induced HSCs. (A) Effect of OPMCM on expression of Smad2/3 and the phosphorylation of Smad2/3 (HSCs were treated with or without OPMCM for 36 h before Western blotting). (B) Effect of SB-431542 on expression of the phosphorylation Smad2/3 (upper panel) and Smad2/3 (lower panel) in HSCs induced with OPMCM. (C) Effect of SB-431542 on transcription of Smad2 and Smad3 in HSCs induced with OPMCM. HSCs were treated with OPMCM for 12 h before adding SB-431542 for 12 h incubation for RT-PCR analysis or 24 h incubation for Western blotting.

Figure 8

Fig. 8. Effect of PAE on the expression of Smad2/3 or Smad2/3 phosphorylation. HSCs were treated with OPMCM for 12 h before adding different PAE concentrations ranging from 0 to 120 mg/l for 24 h incubation for Western blotting. (A) The levels of phosphor-Smad2/3 protein (upper panel) and Smad2/3 protein (lower panel) were measured by Western blotting. (B) Values of densitometric scan are means±s.d. of 3 experiments. (C) Ratio of phosphor-Smad2/3 to Smad2/3. Experiments were performed in triplicate and data presented are representative of 3 independent experiments.

Figure 9

Fig. 9. Effect of PAE on the expression of Smad2/3 without OPMCM stimulation in HSCs. HSCs were treated with different PAE concentrations ranging from 0 to 120 mg/l for 24 h incubation for Western blotting. PAE had no influence on Smad2/3 at protein levels even when the concentration was increased up to 120 mg/l. Experiments were performed in triplicate (data not shown).

Figure 10

Fig. 10. PAE specifically down-regulates transcription of Smad3. HSCs were pre-incubated with OPMCM for 12 h before different PAE concentrations were added ranging from 0 to 120 mg/l for 12 h incubation for RT-PCR, or for 24 h for Western blot. (A) The levels of Smad2, Smad3, Smad4, and Smad7 were measured by PT-PCR. (B) The levels of Smad4, and Smad7 were measured by Western blotting.